Literature DB >> 15855164

Mitochondrial Dok-4 recruits Src kinase and regulates NF-kappaB activation in endothelial cells.

Seigo Itoh1, Serge Lemay, Masaki Osawa, Wenyi Che, Yuntao Duan, Andrew Tompkins, Paul S Brookes, Shey-Shing Sheu, Jun-Ichi Abe.   

Abstract

The downstream of kinase (Dok) family of adapter proteins consists of at least five members structurally characterized by an NH2-terminal tandem of conserved pleckstrin homology and phosphotyrosine binding domains linked to a unique COOH-terminal region. To determine the role of the novel adapter protein Dok-4 in endothelial cells, we first investigated the cell localization of Dok-4. Most surprisingly, immunofluorescence microscopy, cell fractionation studies, and studies with enhanced green fluorescent protein chimeras showed that wild type Dok-4 (Dok-4-WT) specifically localized in mitochondria. An NH2-terminal deletion mutant of Dok-4 (Dok-4-(deltaN11-29)), which lacks the mitochondrial targeting sequence, could not accumulate in mitochondria. Co-immunoprecipitation revealed an interaction of c-Src with Dok-4-WT in endothelial cells. Most interestingly, overexpression of Dok-4-WT, but not Dok-4-(deltaN1-99), increased mitochondrial c-Src expression, whereas knock-down of endogenous Dok-4 with a small interfering RNA vector greatly inhibited mitochondrial localization of c-Src, suggesting a unique function for Dok-4 as an anchoring protein for c-Src in mitochondria. Dok-4-WT significantly decreased 39-kDa subunit complex I expression. PP2, a specific Src kinase inhibitor, prevented the Dok-4-mediated complex I decrease, suggesting the involvement of Src kinase in regulation of complex I expression. Dok-4-WT enhanced tumor necrosis factor-alpha (TNF-alpha)-mediated reactive oxygen species (ROS) production, supporting the functional relevance of a Dok-4-Src-complex I/ROS signaling pathway in mitochondria. Finally, Dok-4 enhanced TNF-alpha-mediated NF-kappaB activation, whereas this was inhibited by transfection with Dok-4 small interfering RNA. In addition, Dok-4-induced NF-kappaB activation was also inhibited by transfection of a dominant negative form of c-Src. These data suggest a role for mitochondrial Dok-4 as an anchoring molecule for the tyrosine kinase c-Src, and in turn as a regulator of TNF-alpha-mediated ROS production and NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855164     DOI: 10.1074/jbc.M410262200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Mitochondrial c-Fos May Increase the Vulnerability of Neuro2a Cells to Cellular Stressors.

Authors:  Yuki Kambe; Atsuro Miyata
Journal:  J Mol Neurosci       Date:  2016-01-14       Impact factor: 3.444

Review 2.  Mitochondrial superoxide dismutase--signals of distinction.

Authors:  Sumitra Miriyala; Aaron K Holley; Daret K St Clair
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

3.  Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer.

Authors:  Tong Li; Beifang Li; Asgharpour Sara; Christine Ay; Wing Yan Leung; Yanquan Zhang; Yujuan Dong; Qiaoyi Liang; Xiang Zhang; Philip Weidner; Tobias Gutting; Hans-Michael Behrens; Christoph Röcken; Joseph Jy Sung; Matthias P Ebert; Jun Yu; Elke Burgermeister
Journal:  Oncoimmunology       Date:  2019-08-21       Impact factor: 8.110

4.  Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1.

Authors:  Rong Tao; Sun Hee Kim; Norman Honbo; Joel S Karliner; Conrad C Alano
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

5.  Cardiac mitochondrial damage and inflammation responses in sepsis.

Authors:  Qun Zang; David L Maass; Sue Jean Tsai; Jureta W Horton
Journal:  Surg Infect (Larchmt)       Date:  2007-02       Impact factor: 2.150

Review 6.  Mitochondrial protein phosphorylation: instigator or target of lipotoxicity?

Authors:  Wolfgang F Graier; Roland Malli; Gerhard M Kostner
Journal:  Trends Endocrinol Metab       Date:  2009-04-07       Impact factor: 12.015

7.  Epidermal growth factor receptor translocation to the mitochondria: regulation and effect.

Authors:  Michelle L Demory; Julie L Boerner; Robert Davidson; William Faust; Tsuyoshi Miyake; Icksoo Lee; Maik Hüttemann; Robert Douglas; Gabriel Haddad; Sarah J Parsons
Journal:  J Biol Chem       Date:  2009-10-19       Impact factor: 5.157

8.  Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytes.

Authors:  Rong Tao; Joel S Karliner; Ursula Simonis; Jie Zheng; Jianqing Zhang; Norman Honbo; Conrad C Alano
Journal:  Biochem Biophys Res Commun       Date:  2007-08-14       Impact factor: 3.575

9.  c-Jun N-terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial Src.

Authors:  Sanda Win; Tin Aung Than; Robert Win Maw Min; Mariam Aghajan; Neil Kaplowitz
Journal:  Hepatology       Date:  2016-03-15       Impact factor: 17.425

Review 10.  Mitochondria and Ca(2+) signaling: old guests, new functions.

Authors:  Wolfgang F Graier; Maud Frieden; Roland Malli
Journal:  Pflugers Arch       Date:  2007-07-05       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.